PGM
LYRA

Parian Global Management’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Parian Global Management’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,426
Closed -$1.11M – 40
2021
Q3 		$1.11M Buy
+2,426
New +$917K 0.77% 27

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Parian Global Management's LYRA Position: Q4 2021 in Review

Parian Global Management sold out of LYRA THERAPEUTICS INC (LYRA) in Q4 2021, closing a stake of 2,426 shares — an estimated $1.11M sold.

Parian Global Management first reported a position in LYRA in Q3 2021 and held it in 1 quarter. The position peaked at $1.11M in Q3 2021. 33 funds tracked by Wall St. Rank hold LYRA as of Q4 2021.

  • Parian Global Management reported no remaining LYRA THERAPEUTICS INC position as of Q4 2021 after selling out during the quarter.
  • Parian Global Management sold 2,426 LYRA THERAPEUTICS INC shares in Q4 2021, an estimated $1.11M.
  • Parian Global Management first reported a position in LYRA THERAPEUTICS INC in Q3 2021 and held it in 1 quarter.
  • Parian Global Management's LYRA THERAPEUTICS INC position peaked at $1.11M in Q3 2021.
  • 33 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q4 2021.

Based on Parian Global Management's 13F filing for Q4 2021, filed 14 Feb 2022.